IGF2BP1 and neoplasm: How IGF2BP1 or SRF influence tumor cell viability at low adhesion and mitogen stimulation (FBS, 1%) was analyzed by anoikis resistance assays upon depleting both factors in ES-2 cells (Figure 4E).